Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29886444 | 0.84 | GAA (0.37) | APEX1TDP1TSHRGAAMAPT | |
| SCHEMBL311663 | 0.82 | AHR (0.44) | APEX1AHRCA1CA2CA4 | |
| SCHEMBL30310848 | 0.79 | CA1 (0.52) | APEX1CA1CA2CA4CA6 | |
| SCHEMBL11272164 | 0.79 | CA1 (0.52) | APEX1CA1CA2CA4CA6 | |
| SCHEMBL11525099 | 0.72 | APEX1 (0.33) | APEX1TSHR | |
| SCHEMBL2368449 | 0.72 | CA1 (0.52) | CA1CA2CA4CA6TDP1 | |
| SCHEMBL356698 | 0.71 | AHR (0.50) | APEX1AHRCA1CA2CA4 | |
| SCHEMBL4586367 | 0.69 | TSHR (0.40) | APEX1CYP3A4TSHR | |
| SCHEMBL31406990 | 0.67 | HPRT1 (0.38) | TDP1TSHRMAPT | |
| SCHEMBL18068460 | 0.67 | SRC (0.41) | AHRCA1CA2CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108689986-B | Anthracene luminescent material and preparation method and application thereof | 广东工业大学 | 2021-07-09 | — | — | CN | disclosed |